Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Repeated may slow skin recovery by injuring regrowing

Repeated may interrupt , slowing recovery of sensation, and strength despite . Testing in animals and would reject this mechanism if is normal and selectively preserving it has no effect.

Stage of verification

  1. Hypothesis published2026-09-25
  2. Indirect evidenceAssessed at 5 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionBrain and nervous system

Ageing mechanism

Main connectionAltered intercellular communication

Direction

Kind of knowledge gap

The question is designed to try to disprove the leading explanation.Adversarial gap

A double ring marks the main placement where a group contains several values.

Lens
Peripheral axon regeneration
Goal
Определение терапии с полным и устойчивым восстановлением функций кожи
Competing hypotheses
2
Published
2026-09-25
As a hypothesis
9 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
9 / 10Decisive experiment
3 / 10Silver-bullet potential
5 / 10Support from research
Poster: Treatment reinjures sensory axons
PosterOpen the sheet full size2026-09-26

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Organ structure

    Nerve fibers involved in sensation and local neural support for tissue repair

    Where this hypothesis actsSkin undergoing repeated before have fully regenerated

    Hypotheses on this target 1
    Sensory axonsFunction restoration. Hypotheses on this target 0Remodelling. Hypotheses on this target 0Tissue graft. Hypotheses on this target 0Load normalisation. Hypotheses on this target 0
    • Function restoration
    • Remodelling
    • Tissue graft
    • Load normalisation

    What is proposed

    Preserve and allow to finish between treatments

    With whatNot stated in the record

    HowSelectively preserve while maintaining comparable injury to other tissues; no specific preservation technique is stated

    Possible result

    Possible prevention of progressive slowing of sensory, barrier and

    From the recordСелективное сохранение аксонов при сопоставимом повреждении других тканей должно предотвращать ухудшение всех трех направлений.

  2. Signalling molecule

    Calcitonin gene-related peptide, a signal released by sensory nerve endings

    Where this hypothesis actsDenervated skin in a proposed preclinical experiment

    Hypotheses on this target 2
    CGRPLower level. Hypotheses on this target 0Synthesis suppression. Hypotheses on this target 0Neutralisation. Hypotheses on this target 0Supplementation. Hypotheses on this target 22Accelerated excretion. Hypotheses on this target 0
    • Lower level
    • Synthesis suppression
    • Neutralisation
    • Supplementation2
    • Accelerated excretion

    What is proposed

    Supplementation

    Restore signaling despite persistent

    With whatNot stated in the record

    HowNot stated in the record

    Possible result

    Possible partial recovery of barrier and repair responses, with sensory deficits remaining

    From the recordВ доклиническом опыте восстановление сигнала пептида CGRP при сохраняющейся денервации должно улучшать часть барьерного и репаративного ответа, но оставлять сенсорный дефицит

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTCGRP. Hypotheses on this target 2CGRP
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and beddingSensory axons. Hypotheses on this target 1Sensory axons
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Skin that produces more structural material after treatment may still become slower to recover from everyday strain. The unexpected move is to locate the accumulating damage in regrowing , which carry information about touch and other sensations, even after the skin surface has closed. This is a proposal generated by the pipeline, not a measured result of repeated treatment.

The proposed mechanism, link by link
  1. A treatment wound closes at the surface while and , the cells that support peripheral nerve fibres, remain incompletely restored.
  2. The next treatment is proposed to injure those still-regrowing .
  3. Repeated interruption is proposed to turn temporary nerve loss followed by regrowth into accumulating , meaning loss of nerve supply.
  4. Reduced nerve supply is proposed to delay sensation and weaken local signals that help inflammation subside and tissue repair proceed.
  5. Weaker repair support is proposed to slow recovery of the protective barrier and strength, while , cells that make tissue support material, continue producing .
  6. Allowing , the return of nerve supply, to finish between treatments is predicted to stabilize recovery across cycles; the supplied text calls its target but does not define that measure.
A picture for it

A road can be resurfaced while the cables beneath it are still being repaired. Repeatedly reopening it before that repair finishes could leave an intact-looking surface above increasingly incomplete connections.

Where the picture breaks: Skin nerves are living structures that regrow and signal to surrounding cells. The picture does not establish their recovery time, their vulnerability to another treatment or their contribution to skin strength.

  1. Master questionstep 01 of 04

    A therapy is sought that would bring the skin function of middle-aged people up to that of young people.

    Rests on: The goal itself sets youthful skin function as the target; it does not establish that this target can be reached.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    The desired therapy must restore skin functions fully and durably.

    Rests on: The original goal calls for function comparable to young skin. This stage adds completeness and durability as requirements.

    Assumption

    Full and sustained restoration is adopted as the success criterion; the original goal does not specify how long improvement must last or how completeness would be assessed.

  3. Gap questionstep 03 of 04

    Repeated , which injures small areas while leaving surrounding tissue intact, might reduce the skin's remaining capacity to repair itself even as , a structural protein, increases. The proposed warning sign is progressively slower recovery of the skin's protective barrier, strength and sensation after the same everyday strain.

    Rests on: The demand for durable function motivates checking whether repeated treatment undermines later recovery. The preceding stage does not identify this treatment or establish that slower recovery means repair capacity has been depleted.

    Assumption

    Repeated is selected as the setting, and slower recovery across cycles is treated as a possible sign of declining repair capacity. Neither choice is established by the preceding goal.

  4. Hypothesisstep 04 of 04

    Repeated treatment is proposed to injure immature , the long extensions of nerve cells, before they finish regrowing. Accumulating loss of nerve supply could then delay sensation and tissue repair while production continues.S1

    Rests on: The preceding question supplies the pattern needing explanation: more alongside slower functional recovery. Source S1, an abstract from Cell and Tissue Research in 2002, reports delayed surface repair and reduced wound shrinkage after partial sensory nerve loss in developing rats; it does not establish repeated treatment injury to regrowing nerves or the proposed sequence in middle-aged human skin.

    Supported by literature

What is carried, and what is not. The two screened sources speak to two separate links: S1, available only as a 2002 Cell and Tissue Research abstract, connects sensory nerve loss with poorer wound healing in developing rats, without testing repeated ; S2, a 2010 PLOS ONE study, reports diminished regrowth after a second amputation of , whisker-like appendages, without identifying nerve injury as the cause or testing skin treatment. Neither establishes the proposed sequence from repeated injury of regrowing nerves to worsening recovery of barrier, strength and sensation despite continued production.S1S2

Where the reasoning is carried by something unstated · 2
  • Goal pillar. Full and sustained restoration is adopted as the success criterion; the original goal does not specify how long improvement must last or how completeness would be assessed.
  • Gap question. Repeated is selected as the setting, and slower recovery across cycles is treated as a possible sign of declining repair capacity. Neither choice is established by the preceding goal.
How a result here could mislead · 3
  • Better recovery after longer intervals could be credited to completed nerve regrowth even though the extra time also lets other repair processes finish. What closes it: Nerve density and maturity must be measured separately from functional recovery. The proposed selective nerve-preservation comparison must also establish comparable injury to other tissues; interval changes alone cannot distinguish the nerve explanation from the rivals.
  • An intervention intended to preserve could appear to disprove the hypothesis if recovery still worsens, even though the intervention failed to preserve working nerves. What closes it: The comparison must verify both nerve preservation and function, including , the minimum stimulus needed to produce a detectable sensation, and the , the release or action of small nerve-signalling proteins after stimulation.
  • Improved barrier repair after restoring calcitonin gene-related peptide, abbreviated , a nerve-signalling molecule, could be mistaken for restored nerve supply or proof that nerve loss caused the original deterioration. What closes it: Persistent nerve loss, barrier recovery and sensation must be measured separately. The proposal predicts only partial repair improvement from restoring this signal while nerves remain absent; recovering sensation is a separate prediction tied to restoring the themselves.

What would make this wrong. Progressively slower barrier, strength and sensory recovery despite normal nerve supply and function, together with no benefit from verified selective axon preservation under comparable injury to other tissues, would contradict the proposed nerve-loss explanation. The supplied proposal provides no numerical criteria for normal nerve function or a meaningful protective effect.

What it would change. If this mechanism held, progress toward youthful skin function would require accounting for nerve recovery between repeated treatments, alongside production and surface closure. It would identify one proposed reason treatment could undermine later repair. Results in animals or laboratory-grown skin supplied with nerves would still not establish complete, lasting restoration in middle-aged people, and the supplied material defines neither youthful performance nor .

Sources read · 2

6 literature searches, 1 full text, 1 abstract-only; 2 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers itAbstract only

Impaired cutaneous wound healing after sensory denervation in developing rats: effects on cell proliferation and apoptosis. · Cell and tissue research · 2002

“We conclude that partial loss of sensory innervation impairs cutaneous wound healing in developing rats, as manifested by delayed re-epithelialization and failure of the wound area to decrease normally through at least 21 days.”

Does not settle: Исследование на развивающихся крысах с денервацией капсаицином не проверяет повторные циклы фракционного воздействия, повреждение регенерирующих аксонов или шванновских клеток, восстановление чувствительности, иммунное разрешение, прочность кожи, синтез коллагена либо интервал, необходимый для завершения реиннервации.

S2Partly answers it

Development and regeneration of the zebrafish maxillary barbel: a novel study system for vertebrate tissue growth and repair. · PloS one · 2010

“However, the regenerative response to the second round of injury was diminished, both in the number of individuals responding and the length of the structures produced.”

Does not settle: Источник описывает повторную ампутацию усиков у рыбок данио. Он не устанавливает эффект фракционного воздействия на кожу, незрелые сенсорные аксоны или шванновские клетки, сроки реиннервации, восстановление чувствительности, иммунное разрешение, барьер, прочность кожи, синтез коллагена или SPV_9.

The gap this hypothesis explains

Two live hypotheses pull in opposite directions here, and the field has not chosen between them.

Does repeated treatment of tiny skin areas deplete repair capacity even when increases?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Ускоряет ли повторное истощение , несмотря на рост , если после одинаковой бытовой нагрузки восстановление барьера, прочности и чувствительности замедляется от цикла к циклу?

What this question is asking

The question concerns whether repeated skin treatment preserves the ability to recover from everyday stress or gradually wears that ability down. It asks whether , which acts on small areas within the treated skin, accelerates loss of repair capacity if later treatment cycles are followed by slower recovery of the skin’s protective barrier, strength and sensitivity after the same everyday stress. It assumes that can increase alongside this functional decline, but that combination is not established by the supplied evidence. The relevant comparison is recovery after successive cycles versus earlier cycles and skin receiving fewer or no treatments; the stated longer-term requirement is recovery as fast as in young skin, with acceptable safety, for at least 10 years.

What the terms mean
Fractional treatment
Treatment delivered to small areas within a larger skin region. The supplied sources discuss laser approaches and also a comparison involving radiofrequency; the input does not identify one precise treatment method or schedule for the proposed question.
Fractional laser treatment and microscopic treatment zones
Laser treatment uses light to act on tissue. S3 calls the small wounds created by its fractional approach microscopic treatment zones; these are the local injuries from which healing follows.
Radiofrequency treatment
A treatment category using energy from radiofrequency electrical signals. It appears as a comparator in S4, but the supplied quotation does not establish its effects on repeated functional recovery.
Treatment cycle
One treatment episode and its subsequent recovery period in the question’s repeated sequence. Multiple passes during one procedure do not by themselves establish multiple cycles separated by recovery.
Regenerative reserve or repair capacity
The proposed remaining ability of skin to repair damage over repeated challenges. The input does not define a directly measured quantity or a threshold at which this reserve counts as depleted.
Collagen
A structural protein that helps give skin support and strength and also forms part of scar tissue. Its amount and its organization are different properties; the supplied findings do not establish that either alone measures recovery capacity.
Skin barrier
The skin’s protective function at its surface. Barrier recovery means restoration of that protection after disruption, rather than simply a change in appearance.
Skin strength
The skin’s ability to withstand physical forces without damage. The input does not specify how this would be measured after everyday stress.
Skin sensitivity
The skin’s ability to register sensation. The input does not specify which sensations or measurements would count as recovery.
Fibroblast activation
Increased activity in cells that produce and other supporting material in skin. S9 reports signs of this activity, which is distinct from demonstrating increased long-term repair capacity.
Fibrosis
Accumulation of scar-like supporting tissue. The pipeline raises it as a possible consequence of repeated stimulation, but the supplied evidence does not establish that consequence in the proposed setting.
Carbon dioxide laser
A laser named for the gas used to generate its treatment light. Sources describing this laser concern particular treatment settings and do not establish the effects of every fractional method.
Low-intensity green laser treatment
An additional light treatment used after fractional laser exposure in S10. Its reported effect cannot be treated as the effect of alone.
Skin graft
Skin moved to cover another area of the body. S2 includes treatment of these areas as well as burn scars, which differs from treatment aimed at restoring youthful function in middle-aged skin.
Depressed acne scars
Indented scars left after acne. S8 concerns these scars, rather than recovery of otherwise unspecified middle-aged skin after everyday stress.
Hypertrophic and keloid scars
Two forms of raised scarring: hypertrophic scars remain within the original injury area, while keloid scars extend beyond it. S5 addresses treatment effectiveness for these conditions.
What the question takes for granted
Premise only partly supported
can increase after while recovery of the , strength and sensitivity after identical everyday stress slows from cycle to cycle, potentially indicating depletion of .

is a structural protein in skin, while means the proposed capacity to keep repairing damage over repeated challenges. The question entertains a mismatch in which more structural material accompanies progressively poorer recovery of protection, strength and sensation. That mismatch would make increased an insufficient sign that repeated treatment preserves youthful function.

S8 describes stimulation of fibers, and S9 reports reorganization and signs of activation in -producing cells. These support a narrower premise that can affect , not the full claim that increases while functional recovery deteriorates across cycles. None of the supplied sources establishes that deterioration or identifies depletion of repair capacity as its cause. The supplied input labels earlier pipeline nodes as allowing depletion and , but provides no source evidence establishing those claims.S8S9

The same question asked without the part nothing read establishes:

  • Does repeated change recovery of protection, strength and sensitivity after identical everyday stress, and how do those changes relate to ?
  • Does repeated preserve recovery as fast as in young skin and acceptable safety for at least 10 years?
What turns on the answer
  • Repeated treatment depletes repair capacity Under this conditional outcome, successive treatments reduce the skin’s remaining ability to repair itself, so the same later stress is followed by slower recovery. If also increases, that increase would coexist with declining function and would not establish lasting restoration to a youthful condition.
  • Repeated treatment preserves repair capacity Under this conditional outcome, successive treatments leave the ability to recover intact despite repeated exposure. changes could then coexist with preserved function, although the separate requirement for acceptable safety over at least 10 years would still need to be established.
  • Recovery slows, but depletion is not established Under this conditional outcome, slower recovery demonstrates a functional change without identifying why it occurs. Calling that change depletion of repair capacity would go beyond the evidence, even if increased were documented at the same time.
Why it matters

The proposed concern follows a sequence: treatment affects small areas of skin, healing follows, and the skin must still recover from later everyday stress. A source describes fractional laser treatment as creating small wounds, while other sources describe production or reorganization after treatment; these findings concern different parts of that sequence [S3, S8, S9]. If increases while recovery becomes slower, counting alone would miss the functional deterioration described in the question. Conversely, treating slower recovery as proof that repair capacity has been exhausted would assign a cause that the supplied sources have not established.

What is already established

RL-3 улучшает отдельные показатели; узлы RL-1 и RL-2 допускают истощение резерва и при повторной стимуляции.

What would have to be true

Повторное лечение сохраняет молодую скорость функционального восстановления и приемлемую безопасность на протяжении минимум 10 лет.

What is missing

Рост может сопровождаться ухудшением восстановления после последующих нагрузок; направленность накопленного эффекта требует прямой проверки.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Каждый следующий цикл повторно повреждает еще незрелые . Поверхность кожи успевает закрыться, однако и поддерживающие их восстанавливаются медленнее. Повторная травма прерывает этот процесс и создает накопленную . Она прямо задерживает восстановление чувствительности и ослабляет местную нервную поддержку и , замедляя восстановление барьера и прочности. продолжают отвечать на повреждение . Завершение между процедурами должно стабилизировать .

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

Ухудшению барьерного и должно предшествовать увеличение времени и снижение . при сопоставимом повреждении других тканей должно предотвращать ухудшение всех трех направлений. В восстановление сигнала при сохраняющейся должно улучшать часть барьерного и , но оставлять ; восстановление самих должно устранять и его. Нормальная и отсутствие эффекта ее селективного сохранения опровергнут эту гипотезу.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable temporal ordering, selective preservation effects, different outcomes from peptide-signal versus axon restoration, and an explicit rejection condition. No rival prediction was supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Плотность и зрелость , и динамику заживления можно измерять раздельно. проводят в и . Простое увеличение интервала между процедурами недостаточно специфично, поскольку одновременно меняет множество процессов ремонта.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

Ухудшению барьерного и должно предшествовать увеличение времени и снижение . при сопоставимом повреждении других тканей должно предотвращать ухудшение всех трех направлений. В восстановление сигнала при сохраняющейся должно улучшать часть барьерного и , но оставлять ; восстановление самих должно устранять и его. Нормальная и отсутствие эффекта ее селективного сохранения опровергнут эту гипотезу.

  • What would separate them

    Repeated fractional skin injury may slow repair by doubling genomes without cell division predicts: В отслеживаемых увеличение должно предшествовать замедлению восстановления после следующей нагрузки. В предотвращение повторного без должно сохранять скорость восстановления барьера, механических свойств и при сопоставимых исходном повреждении, и числе клеток. Пространственно правильная подача или восстановление нервной активности без изменения не должны полностью устранять дефект. Отсутствие накопленной либо сохранение функционального ухудшения после ее предотвращения опровергнет гипотезу.

  • What would separate them

    Loss of positional signals may slow skin repair by disrupting tissue organization predicts: При одинаковых площади и глубине повреждения, числе выживших клеток и количестве восстановление должно зависеть от сохранности конкретных сочетаний . В модели повторного повреждения пространственно правильное восстановление этих сигналов должно ускорять ремонт; те же молекулы в тех же суммарных количествах, но с перемешанным расположением, такого эффекта не дадут. Предварительно измеренная должна предсказывать ухудшение на новых образцах. Отсутствие преимущества правильного расположения или независимости предсказания от общей потери ткани опровергнет механизм.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.